UPDATE 3-Verizon's bid challenges AT&T's offer for Straight Path-source
* Straight Path shares up 6.4 pct at $118, above the bid price (Adds that new bidder for Straight Path is Verizon)
Dec 19 Redhill Biopharma Ltd:
* Redhill Biopharma Ltd - first patient dosed in phase ib/ii study with yeliva for multiple myeloma
* Phase Ib study to evaluate yeliva is planned to be initiated in first half of 2017 Source text for Eikon: Further company coverage:
PONTE VEDRA BEACH, Fla., April 25 Wells Fargo & Co shareholders approved all 15 directors nominated to the bank's board on Tuesday, capping a contentious annual meeting with several directors at risk of facing a no-confidence vote.